The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety outcomes of obecabtagene autoleucel (obe-cel) stratified by age in patients (pts) with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL).
 
Bijal Shah
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; AstraZeneca; Autolus; Bristol-Myers Squibb/Celgene; Deciphera; Jazz Pharmaceuticals; Kite, a Gilead company; Lilly; Pepromene; Pfizer; Takeda
Research Funding - Kite/Gilead (Inst); Kite/Gilead (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb/Celgene; Kite, a Gilead company; Kite, a Gilead company; Lilly; MorphoSys; Pfizer
 
Deborah Yallop
Employment - King's College Hospital NHS Foundation Trust
Consulting or Advisory Role - Amgen, Clinigen, Gilead Sciences, Pfizer, Autolus Therapeutics
Research Funding - Servier (Inst)
Travel, Accommodations, Expenses - Amgen, Kite/Gilead, Servier
 
Elias Jabbour
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Ascentage Pharma; Autolus; Bristol-Myers Squibb; Genentech; Novartis; Pfizer; Taiho Pharmaceutical; Takeda; TargetRX; Terns Pharmaceuticals
Research Funding - Abbvie; Adaptive Biotechnologies; Amgen; Ascentage Pharma Group; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Novartis; Pfizer; Taiho Pharmaceutical; Takeda; Terns Pharmaceuticals; TGRX
Travel, Accommodations, Expenses - Aptitude Health; Autolus; Daiichi Sankyo Nordics; HMP Education; MD Education; Nucleus Global; ONVIV; Pfizer
 
Pere Barba
Research Funding - Allogene, Amgen, Bristol-Myers Squibb, InCyte, Gilead Sciences, Jazz Pharmaceuticals, Miltenyi Biomedicine, Nektar, Novartis, Pfizer, Pierre Fabre (Inst)
 
Eleni Tholouli
Consulting or Advisory Role - Autolus Therapeutics; Bristol-Myers Squibb/Celgene; Gilead Sciences; Janssen; Jazz Pharmaceuticals; Takeda; vertex
Speakers' Bureau - Jazz Pharmaceuticals; Kite/Gilead; Pfizer; Takeda; Vertex
Travel, Accommodations, Expenses - Autolus; Jazz Pharmaceuticals; Kite/Gilead; Menarini
 
Max Topp
Consulting or Advisory Role - Kite/Gilead, Regeneron, AstraZeneca, AbbVie, Incyte
Research Funding - Kite/Gilead, Roche, Regeneron, AstraZeneca (Inst)
 
Karamjeet Sandhu
Research Funding - Autolus Therapeutics (Inst)
 
Sridhar Chaganti
Honoraria - Hartley Taylor Medical; MD Education
Consulting or Advisory Role - Abbvie; Amgen; Autolus; Kite/Gilead; Pierre Fabre; Roche; Sobi
Speakers' Bureau - Abbvie; Kite/Gilead; Pierre Fabre; Roche; Takeda
Research Funding - Autolus (Inst); Genmab (Inst); Kite/Gilead (Inst); MorphoSys
Travel, Accommodations, Expenses - Abbvie; Kite/Gilead; Takeda
 
Jae Park
Stock and Other Ownership Interests - Curocell
Consulting or Advisory Role - Adaptive Biotechnologies; AffyImmune Therapeutics; Allogene Therapeutics; Amgen; Artiva; Autolus; Be Biopharma; BeiGene; Bristol-Myers Squibb/Celgene/Juno; Caribou Biosciences; Galapagos UK; GC Cell; In8Bio; Intellia Therapeutics; Kite, a Gilead company; Kura Oncology; Minerva Biotechnologies; Novartis; Pfizer; Precision Biosciences; SERVIER; SOBI; Synthekine; Takeda
Research Funding - Autolus Therapeutics (Inst); Caribou Biosciences (Inst); Fate Therapeutics (Inst); Genentech/Roche (Inst); Incyte (Inst); Takeda (Inst)
 
Tobias Menne
Honoraria - Amgen, Atara Biotherapeutics, BMS, Daiichi-Sankyo, Gilead Sciences, InCyte, Janssen, Novartis, Pfizer, Roche, Servier, Takeda, Autolus
Consulting or Advisory Role - Amgen, Atara Biotherapeutics, BMS, Daiichi-Sankyo, Gilead Sciences, InCyte, Janssen, Novartis, Pfizer, Roche, Servier, Takeda, Autolus
Speakers' Bureau - Takeda, Kite/Gilead
 
Aaron Logan
Consulting or Advisory Role - Amgen; Kite, a Gilead company; Pfizer; Sanofi; Takeda
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Autolus (Inst); Kadmon (Inst); Kite, a Gilead company (Inst); Talaris (Inst)
 
Daniel DeAngelo
Consulting or Advisory Role - Amgen; Blueprint Medicines; Gilead Sciences; Incyte; Jazz Pharmaceuticals; Novartis; Pfizer; servier; takeda
Research Funding - Abbvie (Inst); Blueprint Medicines (Inst); glycomimetics (Inst); Novartis (Inst)
 
Pierre Lao-Sirieix
Employment - AstraZeneca (I); Autolus Therapeutics
Stock and Other Ownership Interests - Autolus Therapeutics, AstraZeneca
Patents, Royalties, Other Intellectual Property - Medtronic, Medical Research Council UK
 
Ping Wang
Employment - Autolus Therapeutics
Stock and Other Ownership Interests - Autolus Therapeutics
 
Wolfram Brugger
Employment - Autolus Therapeutics
Stock and Other Ownership Interests - Autolus Therapeutics
 
Claire Roddie
Honoraria - Autolus Therapeutics, Bristol Myers Squibb, Gilead
Consulting or Advisory Role - Autolus Therapeutics, Bristol Myers Squibb, Gilead, Janssen